Growing community of inventors

Watertown, MA, United States of America

Dylan C Alexander

Average Co-Inventor Count = 6.85

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Dylan C AlexanderChester A Metcalf, Iii (9 patents)Dylan C AlexanderNing Yin (9 patents)Dylan C AlexanderYu Gui Gu (9 patents)Dylan C AlexanderYong He (9 patents)Dylan C AlexanderJason B Cross (9 patents)Dylan C AlexanderRobert Busch (3 patents)Dylan C AlexanderRoland Ellwood Dolle (2 patents)Dylan C AlexanderJon Christian Baber (2 patents)Dylan C AlexanderDongpeng Wan (2 patents)Dylan C AlexanderChester A Iii Metcalf (0 patent)Dylan C AlexanderDylan C Alexander (9 patents)Chester A Metcalf, IiiChester A Metcalf, Iii (34 patents)Ning YinNing Yin (15 patents)Yu Gui GuYu Gui Gu (11 patents)Yong HeYong He (10 patents)Jason B CrossJason B Cross (9 patents)Robert BuschRobert Busch (3 patents)Roland Ellwood DolleRoland Ellwood Dolle (81 patents)Jon Christian BaberJon Christian Baber (2 patents)Dongpeng WanDongpeng Wan (2 patents)Chester A Iii MetcalfChester A Iii Metcalf (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Cubist Pharmaceuticals, Incorporated (9 from 59 patents)

2. Merck Sharp + Dohme Corp. (2,405 patents)


9 patents:

1. 9108966 - Beta-lactamase inhibitors

2. 8969570 - Beta-lactamase inhibitors

3. 8962844 - 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors

4. 8962843 - 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors

5. 8940897 - 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors

6. 8933233 - 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors

7. 8933232 - 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors

8. 8927724 - Isoxazole beta-lactamase inhibitors

9. 8916709 - 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/3/2025
Loading…